Proposed EU medtech plan would cost about $23B, Eucomed says

09/13/2013 | (Boston)

A Eucomed survey estimates that the proposal to centralize the premarket approval process in Europe would cost medtech companies roughly $23 billion. Eucomed CEO Serge Bernasconi also expressed some concerns about the proposal, saying, "Not only will it kill the SME and innovation ecosystem in Europe with many jobs, it will also limit innovative treatment options being available to patients."

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA